NEXGEL, INC. Inventory Write-down
NEXGEL, INC. (NXGL) reported Inventory Write-down of $0 for the 12-month period ending 2019-12-31, per its 10-K/A filed 2020-04-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2020-04-03
- NEXGEL, INC. inventory write-down for fiscal 2019 was $0.00.
- NEXGEL, INC. inventory write-down for fiscal 2018 was -$5.00K.
| Period end | Inventory Write-down 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K/A · filed 2020-04-03 |
| 2018-12-31 | -$5.00K 10-K/A · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |